Scientists have discovered that cannabidiol (CBD), a compound typically associated with cannabis, has been found in a common Brazilian shrub. This unexpected finding opens up a world of possibilities for producing CBD without the legal hurdles associated with cannabis.
Imagine walking through the lush Brazilian countryside, surrounded by what many consider weeds, only to realize you’re standing amidst a potential goldmine of CBD.
This discovery not only challenges our understanding of where CBD can be sourced but also promises a simpler, cheaper, and legal alternative to cannabis-derived CBD.
The Unexpected Source: Trema micrantha
Scientists at the Federal University of Rio de Janeiro have identified CBD in the fruits and flowers of Trema micrantha, a shrub widely distributed across Brazil. This plant, often dismissed as a weed, could become a valuable resource in the CBD industry.
STOP BUYING GREENS: This Machine Grows $1000s Worth Automatically
✓ Set It & Forget It: Fully Automated Growing
✓ From Seed to Harvest in Days - No Experience Needed
✓ Grow Premium Microgreens Worth $50/lb Year-Round
Note: This is an affiliate link and we may earn a small commission if you purchase at no additional cost. This helps keep our website free to use.
Unlike cannabis, Trema contains CBD but not THC, the psychoactive compound that causes a “high.” (ref)
Molecular biologist Rodrigo Moura Neto, who led the research team, explains that Trema micrantha is a fast-growing plant that can reach up to 66 feet tall. It’s part of the Cannabaceae family, just like cannabis, but without the legal complications.
The plant is often used in reforestation efforts due to its rapid growth, and its leaves have been traditionally used as an analgesic to treat skin rashes.
This unique characteristic makes Trema a potentially legal and abundant source of CBD, especially in countries where cannabis remains illegal. As Moura Neto points out, “It’s a legal alternative to using cannabis.
This is a plant that grows all over Brazil. It would be a simpler and cheaper source of cannabidiol”. (ref)
Implications for the CBD Industry
The discovery of CBD in Trema could have far-reaching implications for the CBD market. With the global CBD market projected to reach nearly $70 billion by 2033, this new source could revolutionize production methods and potentially reduce costs. (ref)
The ability to extract CBD from a common plant without legal restrictions could make CBD more accessible and affordable for consumers worldwide.
Currently, the CBD industry faces numerous regulatory challenges. In many countries, including Brazil, CBD is only approved for medicinal use, with strict regulations on its production and distribution.
The discovery of CBD in Trema could potentially bypass these restrictions, opening up new avenues for CBD production and research.
Moreover, this finding could lead to a diversification of the CBD market. As Moura Neto suggests, many companies are already showing interest in collaborating on the development of non-cannabis-based CBD medications.
This could result in a wider range of CBD products and applications in the future.
Medical Potential & Ongoing Research
CBD has shown promise in treating various conditions, including epilepsy, chronic pain, and anxiety. The research team, led by Moura Neto, plans to scale up their study to identify optimal CBD extraction methods from Trema and analyze its effectiveness in patients.
This research, supported by a substantial grant of $104,000 from the Brazilian government, could pave the way for new CBD-based treatments. The team’s 5-year project aims to identify the best methods for extracting CBD from Trema, followed by studies on its potential as a substitute for medical marijuana.
The medical potential of CBD is significant. For example, in 2018, the FDA approved Epidiolex, a CBD-based drug, for treating certain types of epilepsy. If CBD from Trema proves to be as effective as cannabis-derived CBD, it could lead to the development of new medications without the legal complications associated with cannabis.
Challenges & Future Prospects
While this discovery is exciting, it’s important to note that research is still in its early stages. The effectiveness of Trema-derived CBD compared to cannabis-derived CBD needs to be thoroughly studied.
Additionally, regulatory frameworks may need to be adjusted to accommodate this new source of CBD.
One of the main challenges in the CBD industry is the lack of consistent regulation. In the United States, for instance, the FDA has concluded that existing regulatory frameworks for foods and supplements are not appropriate for CBD. A new regulatory pathway would be needed to balance consumer access with necessary safety oversight.
However, if successful, this could lead to a more sustainable and legally accessible source of CBD, potentially transforming the landscape of natural medicine and wellness products. As Moura Neto emphasizes, the goal is not to patent the plant itself but to make it available for scientists worldwide to research.
Davin is a jack-of-all-trades but has professional training and experience in various home and garden subjects. He leans on other experts when needed and edits and fact-checks all articles.